Nirmal Bio-Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.70 M
- Company Age 20 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.54 Cr
- Revenue Growth 0.03%
- Profit Growth -3.21%
- Ebitda -158.87%
- Net Worth 4.38%
- Total Assets 0.68%
About Nirmal Bio-Chemicals
Nirmal Bio-Chemicals Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 January 2005 and has a history of 20 years. Its registered office is in Jaipur, Rajasthan.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.70 M.
The company currently has active open charges totaling ₹2.54 Cr.
Rajendra Bardiya, Siddharth Bardiya, and Jyoti Bardiya serve as directors at the Company.
Company Details
- Location Jaipur, Rajasthan
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24234RJ2005PTC020195
- Company No.
020195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Nirmal Bio-Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Bardiya  | Director | 06-Dec-2017 | Current |
| Rajendra Bardiya | Director | 28-Jan-2005 | Current |
| Jyoti Bardiya | Director | 28-May-2020 | Current |
Financial Performance of Nirmal Bio-Chemicals.
Nirmal Bio-Chemicals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.03% increase. The company also saw a slight decrease in profitability, with a 3.21% decrease in profit. The company's net worth moved up by a moderate rise of 4.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirmal Bio-Chemicals?
In 2023, Nirmal Bio-Chemicals had a promoter holding of 95.31% and a public holding of 4.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primeark Realty LlpSiddharth Bardiya is a mutual person
- Brawn Yeast Forge Private Limited
Siddharth Bardiya is a mutual person
- Radiuskart India Private Limited
Siddharth Bardiya is a mutual person
Charges (Loans)
₹2.54 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.54 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2024 | Others | ₹1.70 Cr | Open |
| 09 Oct 2018 | Others | ₹8.40 M | Open |
How Many Employees Work at Nirmal Bio-Chemicals?
Unlock and access historical data on people associated with Nirmal Bio-Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirmal Bio-Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirmal Bio-Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
